(Q90473546)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193746%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

review article

1 reference

title

Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic Agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193746%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

author name string

Yehyun Park

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193746%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Jae Hee Cheon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193746%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

publication date

19 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193746%20AND%20SRC:MED&resulttype=core&format=json

Current gastroenterology reports

14 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193746%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193746%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193746%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193746%20AND%20SRC:MED&resulttype=core&format=json

Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report

14 April 2020

cites work

1 reference

12 December 2020

Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody

1 reference

12 December 2020

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case

1 reference

12 December 2020

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

1 reference

12 December 2020

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

1 reference

12 December 2020

Adalimumab: a new modality for Behçet's disease?

1 reference

12 December 2020

Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case

1 reference

12 December 2020

Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab).

1 reference

12 December 2020

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents

1 reference

12 December 2020

Pathogenesis and treatment of intestinal Behçet's disease

1 reference

12 December 2020

Infliximab as an alternative treatment for Behçet disease when other therapies fail.

1 reference

12 December 2020

Efficacy of etanercept in the treatment of a patient with Behçet's disease

1 reference

12 December 2020

Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease

1 reference

12 December 2020

Intestinal Behçet's disease: maintenance of remission with adalimumab monotherapy

1 reference

12 December 2020

Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study.

1 reference

12 December 2020

Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.

1 reference

12 December 2020

Successful treatment with adalimumab in a familial case of gastrointestinal Behcet's disease

1 reference

12 December 2020

Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet's disease

1 reference

12 December 2020

A case of intestinal Behçet's disease treated with infliximab monotherapy who successfully maintained clinical remission and complete mucosal healing for six years.

1 reference

12 December 2020

Clinical course of intestinal Behcet's disease during the first five years

1 reference

12 December 2020

Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa.

1 reference

12 December 2020

A young girl with refractory intestinal Behçet's disease: a case report and review of literatures on pediatric cases who received an anti-tumor necrosis factor agent

1 reference

12 December 2020

Efficacy of infliximab in intestinal Behçet's disease: a Korean multicenter retrospective study

1 reference

12 December 2020

Outcome predictors for intestinal Behçet's disease.

1 reference

12 December 2020

Gastrointestinal manifestations of Behçet's disease in Japan: a study of 43 patients.

1 reference

12 December 2020

The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet's disease: indication of anti-TNFα monoclonal antibodies

1 reference

12 December 2020

Efficacy of infliximab in patients with intestinal Behçet's disease refractory to conventional medication

1 reference

12 December 2020

Refractoriness of intestinal Behçet's disease with myelodysplastic syndrome involving trisomy 8 to medical therapies - our case experience and review of the literature

1 reference

12 December 2020

Anakinra treatment in drug-resistant Behcet’s disease: a case series

1 reference

12 December 2020

Etanercept therapy in Behçet's disease. The tight control strategy in refractory disease.

1 reference

12 December 2020

Etanercept in the treatment of intestinal Behcet's disease

1 reference

12 December 2020

Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series.

1 reference

12 December 2020

Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab

1 reference

12 December 2020

1 reference

12 December 2020

Adalimumab for the treatment of Japanese patients with intestinal Behçet's disease

1 reference

12 December 2020

An update on the diagnosis, treatment, and prognosis of intestinal Behçet's disease

1 reference

12 December 2020

Usefulness of Adalimumab for Treating a Case of Intestinal Behçet's Disease With Trisomy 8 Myelodysplastic Syndrome

1 reference

12 December 2020

Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study

1 reference

12 December 2020

Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients

1 reference

12 December 2020

Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study.

1 reference

12 December 2020

Clinical value of capsule endoscopy for detecting small bowel lesions in patients with intestinal Behçet's disease.

1 reference

12 December 2020

Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?

1 reference

12 December 2020

Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDA.

1 reference

12 December 2020

Tocilizumab in severe and refractory Behcet's disease: Four cases and literature review

1 reference

12 December 2020

Inflammatory bowel disease as a paradoxical effect of anti-TNF alpha therapy

1 reference

12 December 2020

The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study.

1 reference

12 December 2020

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study

1 reference

12 December 2020

Adalimumab effectiveness in Behçet's disease: short and long-term data from a multicenter retrospective observational study.

1 reference

12 December 2020

Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease

1 reference

12 December 2020

Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease

1 reference

12 December 2020

Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease

1 reference

12 December 2020

Intestinal Behçet and Crohn's disease: two sides of the same coin

1 reference

12 December 2020

Mucosal Healing at 14 Weeks Predicts better Outcome in Low-dose Infliximab Treatment for Chinese Patients with Active Intestinal Behcet's Disease.

1 reference

12 December 2020

Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease

1 reference

12 December 2020

Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial

1 reference

12 December 2020

Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study.

1 reference

12 December 2020

A case of refractory intestinal Behçet's disease treated with tocilizumab, a humanised anti-interleukin-6 receptor antibody

1 reference

12 December 2020

Ustekinumab efficacy and safety in mucocutaneous multi-refractory Behçet's disease.

1 reference

12 December 2020

2018 update of the EULAR recommendations for the management of Behçet's syndrome.

1 reference

12 December 2020

Emergence of Inflammatory Bowel Disease During Treatment With Secukinumab

1 reference

12 December 2020

Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study

1 reference

12 December 2020

Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease

1 reference

12 December 2020

Immunopathogenesis of Behcet's Disease

1 reference

12 December 2020

Long-Term Outcome of Ustekinumab Therapy for Behçet's Disease

1 reference

12 December 2020

A Rare Case of New-Onset Ulcerative Colitis following Initiation of Secukinumab

1 reference

12 December 2020

10.1007/S11894-020-00759-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193746%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference